Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Intermediate Risk Prostate Lesions”

7 trials

Showing 7 of 7 results

Not applicableStudy completedNCT01657942
What this trial is testing

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

Who this might be right for
Localized Intermediate Risk Prostate Lesions
InSightec 101
Not applicableActive Not RecruitingNCT02623933
What this trial is testing

MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 60
Not applicableUnknownNCT05599737
What this trial is testing

Stereotactic Prostate Radiotherapy With Dose Escalation Focused on the "Dominant Intra-prostatic Lesion" (DIPL) Delineated by Multi-parametric MRI and 68Ga-PSMA PET (Prostate-SIB-PSMA)

Who this might be right for
Prostate Adenocarcinoma
Centre Leon Berard 30
Testing effectiveness (Phase 2)Study completedNCT02499848
What this trial is testing

Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sophiris Bio Corp 18
Not applicableActive Not RecruitingNCT03998657
What this trial is testing

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

Who this might be right for
Prostate Cancer
InSightec 14
Not applicableWithdrawnNCT03935308
What this trial is testing

Phase I Study MR-guided SBRT to PCa

Who this might be right for
Low or Intermediate Risk Prostate Cancer
Henry Ford Health System
Testing effectiveness (Phase 2)Looking for participantsNCT05851547
What this trial is testing

Dose Escalation For INtraprostatic LEsions

Who this might be right for
Prostatic Neoplasms
Ottawa Hospital Research Institute 54

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation